Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.190
+0.090 (8.18%)
May 8, 2025, 4:00 PM EDT - Market closed
Immuneering Market Cap
Immuneering has a market cap or net worth of $42.71 million as of May 8, 2025. Its market cap has decreased by -15.21% in one year.
Market Cap
42.71M
Enterprise Value
10.56M
1-Year Change
-15.21%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $42.71M, a decrease of -88.33%. That is a compound annual growth rate of -43.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 39.48M | -42.21% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.33B |
| Johnson & Johnson | 374.60B |
| UnitedHealth Group | 358.63B |
| AbbVie | 333.05B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.51B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |